Navigation Links
Spectros Corporation Protects Its Cool White LED Spectroscopy Technology Against Alleged Infringement by Thermo Fisher Scientific
Date:5/6/2009

PORTOLA VALLEY, Calif., May 6 /PRNewswire/ -- Spectros Corporation (Portola Valley, CA) filed in Federal District Court today against Thermo Fisher Scientific (NYSE: TMO), alleging infringement of Spectros' spectroscopy patent family by TMO's Nanodrop 3300 product. Spectros invented and commercialized solid-state, broadband, integrated spectroscopy light sources based on white LEDs, and incorporated these into its flagship T-Stat product, replacing hot light bulbs with cool illuminator sources. The Nanodrop 3300, introduced to market after T-Stat, also incorporates a white LED for spectroscopy. Thermo Fisher promotes this feature as "unconventional," yet TMO holds no published or issued patents covering this approach. Spectros previously approached TMO regarding specific infringed claims on US Patent no. 6,711,426, without success.

"We are surprised that Thermo Fisher Scientific has continued to market devices incorporating our novel and proprietary technology. We trust that, over time, TMO will appreciate the validity and value of the broad, early optical biotechnology intellectual property portfolio held by Spectros," notes David Benaron, CEO.

Spectros and its affiliates have over 80 issued and pending patents in the U.S., Europe, and Japan, forming one of the largest biophotonics intellectual property collections. Spectros' core patents cover optical spectroscopy, fluorimetry, and imaging for use in blood analysis, contrast-targeted cancer surgery, lab-on-chip systems, and benchtop life-sciences equipment. Red Herring reviewed Spectros in a recent market report in which the journal predicted the total market for optical products in optical molecular detection, imaging, and treatment guidance will grow to $12 billion annually over the next five years.

ABOUT SPECTROS: Spectros markets advanced molecular sensing and imaging devices that shed light on ischemia and cancer. The company's lead T-Stat product became the first FDA-approved medical device for the detection of ischemia, an insufficient blood flow to tissue. Spectros is developing follow-on molecular diagnostic tools for breast and prostate cancer currently in phase I/II clinical trials supported by the National Cancer Institute. Spectros is a venture-supported private concern.

ABOUT THERMO FISHER SCIENTIFIC, INC. (NYSE: TMO): Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics..

(Note: Forward-looking statements are intended as a guide only, and do not constitute an offer for investment nor a guarantee of future events or returns. Certain Spectros applications described above have not been reviewed and approved by the FDA, and are for investigational use only. The "About Thermo Fisher Scientific" text is fair-use quoted from Yahoo Finance Business Summary, May 4, 2009. T-Stat is a registered trademark of the Spectros Corporation.)

For further information, contact Ms. Elizabeth van Thillo, Marketing, Spectros Corporation, at info@spectros.com or 650/529.2865


'/>"/>
SOURCE Spectros
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Spectros Corporation Reports 2007 Year-Over-Year Sales Rise 36%
2. Fluorescent glass SRMs are new tool for spectroscopy
3. Shane Lyons Joins GenVault Corporation as Vice President of Sales and Marketing
4. Circ Pharma Limited Enters Into Development Agreement for Chrono Tramadol With Elan Corporation Plc
5. Environmental Tectonics Corporation Expands BioMedical Systems Division Sales Staff
6. Cardiogenesis Corporation to Report First Quarter 2009 Results on May 14th
7. Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009
8. Techne Corporation Declares Dividend and Announces an Increase in Its Share Repurchase Program
9. ETEX Corporation Announces FDA Clearance of Small Size Beta-bsm(TM) Injectable Paste and Gamma-bsm(TM) Moldable Putty
10. MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 4, 2009
11. Volcano Corporation Schedules First Quarter Conference Call, Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today ... a patient who developed lymphedema after being treated for breast cancer benefitted from an ... paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
(Date:6/23/2016)... Pleasant Prairie, WI (PRWEB) , ... June 23, ... ... sciences consultancy focused on quality, regulatory and technical consulting, provides a free ... webinar is presented on July 13, 2016 at 12pm CT at no charge. ...
(Date:6/23/2016)... PUNE, India , June 23, 2016 /PRNewswire/ ... culture media market research report to its pharmaceuticals ... company profiles, product details and much more. ... market spread across 151 pages, profiling 15 companies ... now available at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . ...
Breaking Biology Technology:
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
Breaking Biology News(10 mins):